BridGene Biosciences Showcases Pioneering Cancer Research at International Conference BridGene Biosciences is set to present groundbreaking findings on covalent inhibitors targeting cancer at the upcoming AACR-NCI-EORTC 2025 conference in Boston.

BridGene Biosciences Showcases Pioneering Cancer Research at International Conference #United_States #Boston #Cancer_Research #BridGene #IMTAC

BridGene Biosciences Partners with Takeda for Drug Discovery in Immunology and Neurology BridGene Biosciences has teamed up with Takeda to discover innovative small molecule drugs targeting immunology and neurology. This collaboration aims to advance breakthrough therapies.

BridGene Biosciences Partners with Takeda for Drug Discovery in Immunology and Neurology #USA #San_Jose #Takeda #BridGene #IMTAC